Global antidiabetics market is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth.
Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness.
Global antidiabetics market, by product, 2012 – 2020 (USD Billion)
Request a sample Copy of the Antidiabetics Market Research Report @ https://www.grandviewresearch.com/industry-analysis/antidiabetics-market/request/rs1
Key Takeways Of The Report :
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/904/ibb
Grand View Research has segmented the global antidiabetics market on the basis of product and region:
Global Insulin Product Outlook (Revenue, USD Million, 2012 – 2020)
Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 – 2020)
Antidiabetics Regional Outlook (Revenue, USD Million, 2012 – 2020)
Browse Related Report:
Pruritus Therapeutics Market : https://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market : https://www.grandviewresearch.com/industry-analysis/idiopathic-thrombocytopenic-purpura-itp-therapeutics
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/antidiabetics-market